EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico

Summary

This clinical trial assesses the acceptability and efficacy of Empowered, Queer, Quitting, and Living--New Mexico (EQQUAL-NM), a smoking cessation intervention for sexual and gender minority young adults in New Mexico. Smoking prevalence among sexual and gender minority (SGM) adults in New Mexico is more than twice as high as non-SGM adults. Helping young adult tobacco users to quit is critical, yet there have been few efforts to develop tailored treatments specifically for this population. EQQUAL-NM is a digital smoking cessation intervention designed specifically for SGM young adult smokers in New Mexico and may help them quit smoking.

Conditions

• Cigarette Smoking-Related Carcinoma

Interventions

BEHAVIORAL

Smartphone App-delivered Smoking Cessation Intervention

Receive access to EQQUAL-NM (Program A) intervention

BEHAVIORAL

Smartphone App-delivered Smoking Cessation Intervention

Receive access to EQQUAL-NM (Program B) intervention

OTHER

Health Promotion and Education

Receive text message reminders, motivational messages and prompts via SMS text messages (Program A)

OTHER

Health Promotion and Education

Receive text message reminders, motivational messages and prompts via SMS text messages (Program B)

OTHER

Biospecimen Collection

Complete at-home saliva sample collection

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• National Cancer Institute Center to Reduce Cancer Health Disparities

  collaborator UNKNOWN

• New Mexico State University

  collaborator OTHER

• Fred Hutchinson Cancer Center

  lead OTHER

Principal Investigators

• Jaimee Heffner · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

30 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2025-12-01

Primary Completion

2026-04-01

Completion

2026-04-01

Countries

• United States

Study Locations